skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 2
Patent #:
7662821
Issue Dt:
02/16/2010
Application #:
10962169
Filing Dt:
10/12/2004
Publication #:
20050171109
Pub Dt:
08/04/2005
Inventors:
Hartmut Rehwinkel, Stefan Baeurle, Markus Berger, Norbert Schmees, Heike Schaecke et al
Title:
TETRAHYDRONAPHTHALENE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS ANTI-INFLAMMATORY AGENTS
Assignment: 1
Reel/Frame:
016457/0388Recorded: 04/13/2005Pages: 2
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
REHWINKEL, HARTMUT
Exec Dt:
02/22/2005
BAEURLE, STEFAN
Exec Dt:
02/23/2005
BERGER, MARKUS
Exec Dt:
02/24/2005
SCHMEES, NORBERT
Exec Dt:
02/23/2005
SCHAECKE, HEIKE
Exec Dt:
02/18/2005
KROLIKIEWICZ, KONRAD
Exec Dt:
02/14/2005
MENGEL, ANNE
Exec Dt:
02/09/2005
NGUYEN, DUY
Exec Dt:
02/14/2005
JAROCH, STEFAN
Exec Dt:
02/24/2005
SKUBALLA, WERNER
Exec Dt:
02/17/2005
Assignee:
SCHERING AG
BERLIN, GERMANY 13342
Correspondent:
MILLEN, WHITE, ZELANO & BRANIGAN, P.C.
ARLINGTON COURT PLAZA I
SUITE 1400
2200 CLARENDON BLVD.
ARLINGTON, VA 22201
Assignment: 2
Reel/Frame:
022151/0290Recorded: 01/26/2009Pages: 4
Conveyance:
CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Assignor:
SCHERING AKTIENGESELLSCHAFT
Exec Dt:
12/29/2006
Assignee:
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
MUELLERSTRASSE 178
BERLIN, GERMANY D-13352
Correspondent:
MILLEN, WHITE, ZELANO & BRANIGAN, P.C.
2200 CLARENDON BLVD. SUITE 1400
ARLINGTON, VA 22201

Search Results as of: 05/08/2024 06:01 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT